stockportfolio.pro
COMPASS Pathways plc (CMPS)
Healthcare · Medical Care Facilities · NasdaqGS
COMPASS Pathways plc revenue & earnings — last 7 fiscal years
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | — | — | — | — | — | — | — |
| Net income | $-19.61M | $-60.33M | $-71.74M | $-91.50M | $-118.46M | $-155.12M | $-287.86M |
| Net margin | — | — | — | — | — | — | — |
Source: COMPASS Pathways plc SEC filings (10-K).
Explore 7 years of COMPASS Pathways plc financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CMPS in your portfolio →
COMPASS Pathways plc financial history by metric
About COMPASS Pathways plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
COMPASS Pathways plc — frequently asked questions
What is COMPASS Pathways plc's revenue?
COMPASS Pathways plc (CMPS) reported revenue of $0 for fiscal year 2025, according to its SEC filings.
Is COMPASS Pathways plc profitable?
No — CMPS reported a net loss of $-287.86M in fiscal 2025.
What is CMPS's P/E ratio?
COMPASS Pathways plc trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How much debt does COMPASS Pathways plc have?
As of fiscal year 2025, CMPS carried roughly $31.63M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is COMPASS Pathways plc's market cap?
COMPASS Pathways plc (CMPS) has a market capitalization of about $1.52B, based on the latest data in our nightly-refreshed cache.
When does COMPASS Pathways plc's fiscal year end?
CMPS's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from COMPASS Pathways plc's official SEC filings (10-K and 10-Q), covering 7 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.